Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
6.72
-0.18 (-2.61%)
Jun 2, 2026, 3:04 PM CST
SHE:300942 Market Cap
SHE:300942 has a market cap or net worth of 2.72 billion as of June 2, 2026. Its market cap has decreased by -23.10% in one year.
Market Cap
2.72B
Enterprise Value
2.59B
Revenue
271.53M
Ranking
n/a
PE Ratio
398.55
Stock Price
6.72
Market Cap Chart
Since February 9, 2021, SHE:300942's market cap has decreased from 14.45B to 2.72B, a decrease of -81.16%. That is a compound annual growth rate of -26.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 2.79B | -26.67% |
| Dec 31, 2025 | 3.81B | 10.95% |
| Dec 31, 2024 | 3.44B | -26.69% |
| Dec 29, 2023 | 4.69B | -31.80% |
| Dec 30, 2022 | 6.87B | -40.61% |
| Dec 31, 2021 | 11.57B | -19.92% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guanhao Biotech | 3.14B |
| Landfar Bio-medicine | 3.12B |
| Guangdong VTR Bio-Tech | 3.11B |
| Zhejiang Shouxiangu Pharmaceutical | 3.06B |
| Novoprotein Scientific | 2.97B |
| Beijing Kawin Technology Share-Holding | 2.85B |
| Yantai Zhenghai Biotechnology | 2.83B |
| Zhejiang East Asia Pharmaceutical | 2.68B |